Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 07 02 2019
revised: 19 05 2019
accepted: 18 06 2019
pubmed: 11 9 2019
medline: 17 6 2020
entrez: 11 9 2019
Statut: ppublish

Résumé

Axon pathfinding and synapse formation are essential processes for nervous system development and function. The assembly of myelinated fibres and nodes of Ranvier is mediated by a number of cell adhesion molecules of the immunoglobulin superfamily including neurofascin, encoded by the NFASC gene, and its alternative isoforms Nfasc186 and Nfasc140 (located in the axonal membrane at the node of Ranvier) and Nfasc155 (a glial component of the paranodal axoglial junction). We identified 10 individuals from six unrelated families, exhibiting a neurodevelopmental disorder characterized with a spectrum of central (intellectual disability, developmental delay, motor impairment, speech difficulties) and peripheral (early onset demyelinating neuropathy) neurological involvement, who were found by exome or genome sequencing to carry one frameshift and four different homozygous non-synonymous variants in NFASC. Expression studies using immunostaining-based techniques identified absent expression of the Nfasc155 isoform as a consequence of the frameshift variant and a significant reduction of expression was also observed in association with two non-synonymous variants affecting the fibronectin type III domain. Cell aggregation studies revealed a severely impaired Nfasc155-CNTN1/CASPR1 complex interaction as a result of the identified variants. Immunofluorescence staining of myelinated fibres from two affected individuals showed a severe loss of myelinated fibres and abnormalities in the paranodal junction morphology. Our results establish that recessive variants affecting the Nfasc155 isoform can affect the formation of paranodal axoglial junctions at the nodes of Ranvier. The genetic disease caused by biallelic NFASC variants includes neurodevelopmental impairment and a spectrum of central and peripheral demyelination as part of its core clinical phenotype. Our findings support possible overlapping molecular mechanisms of paranodal damage at peripheral nerves in both the immune-mediated and the genetic disease, but the observation of prominent central neurological involvement in NFASC biallelic variant carriers highlights the importance of this gene in human brain development and function.

Identifiants

pubmed: 31501903
pii: 5566387
doi: 10.1093/brain/awz248
pmc: PMC6763744
doi:

Substances chimiques

Cell Adhesion Molecules 0
NFASC protein, human 0
Nerve Growth Factors 0
Protein Isoforms 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2948-2964

Subventions

Organisme : Medical Research Council
ID : MR/K000608/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N008324/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L01095X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601943
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0802760
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001253
Pays : United Kingdom
Organisme : Medical Research Council
ID : G108/638
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S005021/1
Pays : United Kingdom
Organisme : The Dunhill Medical Trust
ID : R605/0717
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J004758/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P008399/1
Pays : United Kingdom

Investigateurs

Stanislav Groppa (S)
Blagovesta Marinova Karashova (BM)
Wolfgang Nachbauer (W)
Sylvia Boesch (S)
Larissa Arning (L)
Dagmar Timmann (D)
Bru Cormand (B)
Belen Pérez-Dueñas (B)
Jatinder S Goraya (JS)
Tipu Sultan (T)
Jun Mine (J)
Daniela Avdjieva (D)
Hadil Kathom (H)
Radka Tincheva (R)
Selina Banu (S)
Mercedes Pineda-Marfa (M)
Pierangelo Veggiotti (P)
Michel D Ferrari (MD)
Arn M J M van den Maagdenberg (AMJM)
Alberto Verrotti (A)
Giangluigi Marseglia (G)
Salvatore Savasta (S)
Mayte García-Silva (M)
Alfons Macaya Ruiz (AM)
Barbara Garavaglia (B)
Eugenia Borgione (E)
Simona Portaro (S)
Benigno Monteagudo Sanchez (BM)
Richard Boles (R)
Savvas Papacostas (S)
Michail Vikelis (M)
James Rothman (J)
Dimitri Kullmann (D)
Eleni Zamba Papanicolaou (EZ)
Efthymios Dardiotis (E)
Shazia Maqbool (S)
Shahnaz Ibrahim (S)
Salman Kirmani (S)
Nuzhat Noureen Rana (NN)
Osama Atawneh (O)
Shen-Yang Lim (SY)
Farooq Shaikh (F)
George Koutsis (G)
Marianthi Breza (M)
Salvatore Mangano (S)
Carmela Scuderi (C)
Eugenia Borgione (E)
Giovanna Morello (G)
Tanya Stojkovic (T)
Massimo Zollo (M)
Gali Heimer (G)
Yves A Dauvilliers (YA)
Carlo Minetti (C)
Issam Al-Khawaja (I)
Fuad Al-Mutairi (F)
Sherifa Hamed (S)
Menelaos Pipis (M)
Conceicao Bettencourt (C)
Simon Rinaldi (S)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

eNeuro. 2018 Jun 27;5(3):
pubmed: 29963618
Neuron. 2005 Dec 8;48(5):737-42
pubmed: 16337912
Science. 2014 Oct 17;346(6207):318-22
pubmed: 25324381
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Parkinsonism Relat Disord. 2019 Jun;63:66-72
pubmed: 30850329
Nat Neurosci. 2016 Sep;19(9):1210-1217
pubmed: 27455109
Cell. 2018 Aug 9;174(4):999-1014.e22
pubmed: 30096314
Bioinformatics. 2013 Apr 1;29(7):845-54
pubmed: 23407358
Neuroscientist. 2018 Apr;24(2):104-110
pubmed: 28534438
Am J Hum Genet. 2016 Oct 6;99(4):928-933
pubmed: 27616481
Neurol Neuroimmunol Neuroinflamm. 2016 Jun 07;3(4):e238
pubmed: 27308303
Ann Clin Transl Neurol. 2015 Oct;2(10):960-71
pubmed: 26478896
Hum Mol Genet. 2014 May 1;23(9):2279-89
pubmed: 24319099
Acta Neuropathol. 2014 Aug;128(2):161-75
pubmed: 24913350
Rev Neurol (Paris). 2014 Dec;170(12):819-24
pubmed: 25459119
Neurology. 2014 Mar 11;82(10):879-86
pubmed: 24523485
Brain. 2018 Jul 1;141(7):e56
pubmed: 29800077
Am J Pathol. 2012 Oct;181(4):1402-13
pubmed: 22885108
Genet Med. 2016 Jul;18(7):696-704
pubmed: 26633542
Brain. 2018 Jul 1;141(7):1998-2013
pubmed: 29878067
Sci Rep. 2017 Oct 31;7(1):14411
pubmed: 29089585
Hum Mol Genet. 2018 Nov 1;27(21):3669-3674
pubmed: 30124836
Neurol Genet. 2017 Mar 22;3(2):e144
pubmed: 28374019
J Biol Chem. 2014 Mar 14;289(11):7907-18
pubmed: 24497634
J Neurosci. 2012 Apr 4;32(14):4724-42
pubmed: 22492029
J Chem Theory Comput. 2008 Jan;4(1):116-22
pubmed: 26619985
Neuron. 2016 Jan 6;89(1):37-53
pubmed: 26687838
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62
pubmed: 26476454
Genet Med. 2017 Feb;19(2):224-235
pubmed: 27513193
Neurology. 2016 Mar 1;86(9):800-7
pubmed: 26843559
Biopreserv Biobank. 2015 Oct;13(5):311-9
pubmed: 26484571
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809
Am J Hum Genet. 2016 Apr 7;98(4):763-71
pubmed: 27058447
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Neurology. 2013 Aug 20;81(8):714-22
pubmed: 23884033
Mol Psychiatry. 2017 Apr;22(4):615-624
pubmed: 27431290
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
PLoS Comput Biol. 2018 Jan 29;14(1):e1005968
pubmed: 29377902
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
Brain. 2017 Jul 1;140(7):1851-1858
pubmed: 28575198

Auteurs

Stephanie Efthymiou (S)

Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.
Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, Queen Square, London, UK.

Vincenzo Salpietro (V)

Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.
Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, Queen Square, London, UK.

Nancy Malintan (N)

Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, Queen Square, London, UK.

Mallory Poncelet (M)

INSERM U1051, Institut de Neurosciences de Montpellier (INM), Université de Montpellier, Montpellier, France.

Yamna Kriouile (Y)

Unit of Neuropediatrics and Neurometabolism, Pediatric Department 2, Rabat Children's Hospital, and Faculty of Medicine and Pharmacy of Rabat, University Mohammed V of Rabat, Morocco.

Sara Fortuna (S)

Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, Italy.

Rita De Zorzi (R)

Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, Italy.

Katelyn Payne (K)

Riley Hospital for Children, Indianapolis, Indiana, IN, USA.

Lindsay B Henderson (LB)

GeneDx, Gaithersburg, MD, USA.

Andrea Cortese (A)

Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.

Sateesh Maddirevula (S)

Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Nadia Alhashmi (N)

Department of Genetics, College of Medicine, Sultan Qaboos University, Sultanate of Oman.

Sarah Wiethoff (S)

Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.
Center for Neurology and Hertie Institute for Clinical Brain Research, Eberhard Karls-University, Tübingen, Germany.

Mina Ryten (M)

Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, London, UK.

Juan A Botia (JA)

Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, London, UK.
Departamento de Ingeniería de la Información y las Comunicaciones, Universidad de Murcia, Murcia, E, Spain.

Vincenzo Provitera (V)

Department of Neurology, Istituti Clinici Scientifici Maugeri IRCCS, Italy.

Markus Schuelke (M)

Department of Neuropediatrics, Charité Universitätsmedizin Berlin, Germany.

Jana Vandrovcova (J)

Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.

Laurence Walsh (L)

Riley Hospital for Children, Indianapolis, Indiana, IN, USA.

Erin Torti (E)

GeneDx, Gaithersburg, MD, USA.

Valeria Iodice (V)

Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, UK.
Autonomic Unit, National Hospital Neurology and Neurosurgery, UCL NHS Trust, London, UK.

Maryam Najafi (M)

Genome Research Division, Human Genetics Department, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen, The Netherlands.

Ehsan Ghayoor Karimiani (EG)

Genetics Research Centre, Molecular and Clinical Sciences Institute, St George's, University of London, Cranmer Terrace, London, UK.

Reza Maroofian (R)

Genetics Research Centre, Molecular and Clinical Sciences Institute, St George's, University of London, Cranmer Terrace, London, UK.

Karine Siquier-Pernet (K)

Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris, France.

Nathalie Boddaert (N)

Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Department of Pediatric Radiology, Necker Enfants Malades University Hospital, APHP, Paris, France.

Pascale De Lonlay (P)

Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Inserm, U1151, Institut Necker-Enfants Malades, Paris, France.

Vincent Cantagrel (V)

Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris, France.

Mhammed Aguennouz (M)

Department of Clinical and Experimental Medicine, University of Messina, Sicily.

Mohamed El Khorassani (M)

Unit of Neuropediatrics and Neurometabolism, Pediatric Department 2, Rabat Children's Hospital, and Faculty of Medicine and Pharmacy of Rabat, University Mohammed V of Rabat, Morocco.

Miriam Schmidts (M)

Genome Research Division, Human Genetics Department, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen, The Netherlands.
Center for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg University, Faculty of Medicine, Mathildenstrasse 1, Freiburg, Germany.

Fowzan S Alkuraya (FS)

Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Simon Edvardson (S)

Paediatric Neurology Unit, Hadassah Medical Center, Jerusalem, Israel.

Maria Nolano (M)

Department of Neurology, Istituti Clinici Scientifici Maugeri IRCCS, Italy.
Department of Neurosciences, Reproductive and Odontostomatological Sciences, University "Federico II" of Naples, Italy.

Jérôme Devaux (J)

INSERM U1051, Institut de Neurosciences de Montpellier (INM), Université de Montpellier, Montpellier, France.

Henry Houlden (H)

Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH